These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10623328)

  • 21. [Pertussis].
    Nakase Y
    Nihon Rinsho; 1986 Sep; 44(9):2051-6. PubMed ID: 2879051
    [No Abstract]   [Full Text] [Related]  

  • 22. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
    Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
    Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
    Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pertussis epidemics].
    Engell-Nørregård L; Hartzen S; Colding H
    Ugeskr Laeger; 2003 Oct; 165(44):4205-7. PubMed ID: 14621550
    [No Abstract]   [Full Text] [Related]  

  • 26. The resurgence of pertussis.
    Bowman SC
    Ky Nurse; 2008; 56(3):11. PubMed ID: 18686569
    [No Abstract]   [Full Text] [Related]  

  • 27. Pertussis: review of epidemiology, diagnosis, management and prevention.
    Wood N; McIntyre P
    Paediatr Respir Rev; 2008 Sep; 9(3):201-11; quiz 211-2. PubMed ID: 18694712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using computer simulations to compare pertussis vaccination strategies in Australia.
    Hethcote HW; Horby P; McIntyre P
    Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whooping cough.
    Jamieson WM
    Br Med J; 1973 Jan; 1(5847):223-5. PubMed ID: 4346857
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
    Taranger J; Trollfors B; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    J Infect Dis; 2000 Mar; 181(3):1010-3. PubMed ID: 10720524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new era of research into Bordetella pertussis pathogenesis.
    Preston A; Maskell DJ
    J Infect; 2002 Jan; 44(1):13-6. PubMed ID: 11972412
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of pertussis among adolescents by vaccination: taking action on what we know and acknowledging what we do not know.
    Wharton M
    Clin Infect Dis; 2004 Jul; 39(1):29-30. PubMed ID: 15206049
    [No Abstract]   [Full Text] [Related]  

  • 34. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough.
    Kapaskelis AM; Vouloumanou EK; Rafailidis PI; Hatzopoulou P; Nikita D; Falagas ME
    Respir Med; 2008 Nov; 102(11):1586-91. PubMed ID: 18684605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action to be taken when facing one or more cases of whooping-cough].
    Floret D; Bonmarin I; Deutsch P; Gaudelus J; Grimprel E; Guérin N; Guiso N; Morer I
    Arch Pediatr; 2005 Aug; 12(8):1281-91. PubMed ID: 15961299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis: should we vaccinate post transplant?
    Kochethu G; Clark FJ; Craddock CF
    Bone Marrow Transplant; 2006 Apr; 37(8):793-4. PubMed ID: 16518430
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bordetella pertussis: the principal determinants of its pathogenicity].
    Vancea D; Junie M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(1):55-66. PubMed ID: 2551029
    [No Abstract]   [Full Text] [Related]  

  • 38. The Bordetella type III secretion system: its application to vaccine development.
    Abe A; Nagamatsu K; Watanabe M
    Microbiol Immunol; 2008 Feb; 52(2):128-33. PubMed ID: 18380810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic evolution under vaccine pressure: the Bordetella pertussis model].
    Simondon F; Guiso N
    Bull Soc Pathol Exot; 2000 Jul; 93(3):202-5. PubMed ID: 11030058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.